Resistence to cytotoxic therapy: A speculative overview

Annals of Oncology

Volumn 6, Issue 7, 1995, Pages 651-655

  Preisler, H D ^a  

^a RUSH CANCER INSTITUTE   (United States)

Author keywords

Comprehensive resistance; Multidrug resistance; Regrowth resistance

Indexed keywords

ARTICLE; CELL DIVISION; DRUG RESISTANCE; GENE EXPRESSION; GENETICS; HUMAN; MULTIDRUG RESISTANCE; MUTATION; NEOPLASM; PATHOLOGY; TUMOR SUPPRESSOR GENE; APOPTOSIS; CANCER CHEMOTHERAPY; ETIOLOGY; PRIORITY JOURNAL; REVIEW;

CELL DIVISION; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION; GENES, P53; HUMAN; MUTATION; NEOPLASMS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

ALPHA INTERFERON; RETINOIC ACID;

EID: 0028980686     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.annonc.a059279     Document Type: Article

References (34)

1. Biedler J.L. Riehm H. Cellular resistance to actinomycin D in Chinese hamster cells in vitro: Cross-resistance, radioautographic and cytogenetic studies Cancer Res 30 1970 1174 1184
2. Gros P. Neriah Y.B. Croop J.M. Isolation and expression of a complementary DNA that confers multidrug resistance Nature 323 1986 728 731
3. Roninson I.B. Chin J.E. Choi K. Isolation of human mdr DNA sequences amplified in multidrug-resistant KB carcinoma cells Proc Natl Acad Sci USA 83 1986 4538 4542
4. Pastan I. Gottesman M. Multiple-drug resistance in human cancer N Engl J Med 316 22 1987 1388 1393
5. van der Valk P. van Kalken C.K. Ketelaars H. Distribution of multidrug resistance-associated P-glycoprotein in normal and neoplastic human tissues Ann Oncol 1 1990 56 64
6. Gottesman M.M. Pastan I. The multidrug transporter, a doubleedged sword J Biol Chem 263 25 1988 12163 12166
7. Sato H. Gottesman M.M. Goldstein L.J. Expression of the multidrug resistance gene in myeloid leukemias Leuk Res 14 1 1990 11 22
8. Goldstein L.J. Galski H. Fojo A. Expression of a multidrug resistance gene in human cancers J Natl Cancer Inst 81 2 1989 116 124
9. Juliano R.L. Ling V. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants Biochim Biophys Acta 455 1976 152 162
10. Beck W.T. Mueller T.J. Ranzer L.R. Altered surface membrane glycoproteins in vinca alkaloid-resistant human leukemic lymphoblasts Cancer Res 39 1979 2070 2076
11. Kartner N. Evernden-Porelle D. Bradley G. Detection of P-glycoprotein in multidrug-resistant cell lines by monoclonal antibodies Nature 316 1985 820 823
12. Tsuro T. Srigimoto Y. Hamada H. Detection of multidrug P-glycoprotein and mdr1 mRNA in human leukemia cells Jpn J Cancer Res (Gann) 78 1987 1415 1419
13. Inaba M. Kobayashi H. Sakurai Y. Active efflux of daunorubicin and adriamycin in sensitive and resistant sublines of P388 leukemia Cancer Res 39 1979 2200 2203
14. Fojo A. Ahiyama S. Gottesman M.M. Reduced drug accumulation in multiply drug-resistant human KB carcinoma cell lines Cancer Res 45 1985 3002 3007
15. Cole S.P. Chanda E.R. Dicke F.P. Non-P-glycoprotein-mediated multidrug resistance in a small cell lung cancer cell line: Evidence for decreased susceptibility to drug-induced DNA damage and reduced levels of topoisomerase II Cancer Res 51 1991 3345 3352
16. Cole S.P.C. Bhardwaj G. Gerlach J.H. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line Science 258 1992 1650 1654
17. Kruh G.D. Chan A. Myers K. Expression of a complementary DNA library transfer establishes mrp as a multidrug resistance gene Cancer Res 54 1994 1649 1652
18. Zaman G.J.R. Flens M.J. van Leusden M.R. The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump Proc Natl Acad Sci 91 1994 8822 8826
19. Leier I. Jedlitschky G. Buchholz U. The MRP gene encodes and ATP-dependent export pump for leukotriene C4 and structurally related conjugates J Biol Chem 269 1994 27807 27810
20. Marquardt D. Center M.S. Drug transport mechanisms in HL60 cells isolated for resistance to adriamycin: Evidence for nuclear drug accumulation and redistribution in resistant cells Cancer Res 52 1992 3157 3163
21. Scheper R.J. Broxterman H.J. Scheffer G.L. Overexpression of a Mr 110,000 vesicular protein in non-P-glycoprotein-mediated multidrug resistance Cancer Res 53 1993 1475 1479
22. List A.F. Spier C.S. Abbaszadegan M. Non-P-glycoprotein (PGP) mediated multidrug resistance (MDR): Identification of a novel drug resistance phenotype with prognostic relevance in acute myeloid leukemia (AML) Blood 82 1993 443a
23. Morrow C.S. Cowan K.H. Glutathione S-transferases and drug resistance Cancer Cells 2 1990 15 22
24. Ogawa J. Iwazaki M. Inoue H. Immunohistochemical study of glutathione-related enzymes and proliferative antigens in lung cancer Cancer Res 71 7 1993 2204 2209
25. Beck W.T. Unknotting the complexities of multidrug resistance: The involvement of DNA topoisomerases in drug action and resistance J Natl Cancer Inst 81 22 1989 1683 1685
26. Fernandes D.J. Danks M.K. Beck W.T. Decreased nuclear matrix DNA topoisomerase II in human leukemia cells Am Chem Soc Biochem 29 17 1990 4235 4241
27. Ganapathi R. Zwelling L. Constantinou A. Altered phosphorylation, biosynthesis and degradation of the 170 kDa isoform of topoisomerase II in amsacrine-resistant human leukemia cells Biochem Biophys Res Commun 192 3 1993 1274 1280
28. Weichselbaum R.R. Radioresistant and repair proficient cells may determine radiocurability in human tumors Int J Radiat Oncol Biol Phys 12 4 1986 637 639
29. Simon S. Roy D. Schindler M. Intracellular pH and the control of multidrug resistance Proc Natl Acad Sci USA 91 1994 1128 1132
30. Zwelling L.A. Slovak M.L. Doroshow J.H. HT1080/DR4: A P-glycoprotein-negative human fibrosarcoma cell line exhibiting resistance to topoisomerase II-reactive drugs despite the presence of a drug-sensitive topoisomerase II J Natl Cancer Inst 82 1990 1553 1561
31. Ichikawa A. Hotta T. Tagaki N. Mutations of p53 gene and their relation to disease progression in B-cell lymphoma Blood 79 1992 2701 2707
32. Yamaguchi A. Kurosaka Y. Fushida S. Expression of p53 protein in colorectal cancer and its relationship to short-term prognosis Cancer 70 12 1992 2778 2784
33. Callahan R. p53 mutations, another breast cancer prognostic factor J Natl Cancer Inst 84 1992 826 827
34. Visakorpi T. Kallioniemi O.P. Heikkinen A. Small subgroup of aggressive, highly proliferative prostatic carcinomas defined by p53 accumulation J Natl Cancer Inst 84 1992 883 887